{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Image+Quality&page=8", "query": { "intervention": "Image Quality", "page": 8 }, "page_size": 10 }, "pagination": { "page": 8, "page_size": 10, "total_count": 213, "total_pages": 22, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Image+Quality&page=9&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Image+Quality&page=7&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T03:05:24.576Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07771270", "title": "Kosmos Guidance Performance Evaluation Data Annotation", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Heart", "Ultrasound", "Cardiac Ultrasound", "Cardiac Disease" ], "interventions": [ { "name": "Category 1: Corrective Guidance", "type": "DEVICE" }, { "name": "Category 2: Incorrect Scanning Window", "type": "DEVICE" }, { "name": "Category 3: Incorrect Probe Orientation", "type": "DEVICE" }, { "name": "Category 4: Low Confidence Prediction", "type": "DEVICE" }, { "name": "Auto-Capture Frame-Level Re-Annotation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "EchoNous Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 81, "start_date": "2026-06-05", "completion_date": "2026-09-30", "has_results": false, "last_update_posted_date": "2026-08-18", "last_synced_at": "2026-10-20T03:05:24.576Z", "location_count": 1, "location_summary": "Redmond, Washington", "locations": [ { "city": "Redmond", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT07771270" }, { "nct_id": "NCT01986985", "title": "Comparison of 18F FDG PET/CT TO PET MRI", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Any Condition With a Clinical Indication for PET/CT Exam" ], "interventions": [ { "name": "PET/MRI system", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "GE Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 58, "start_date": "2014-01", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2016-03-07", "last_synced_at": "2026-10-20T03:05:24.576Z", "location_count": 2, "location_summary": "San Francisco, California • Stanford, California", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01986985" }, { "nct_id": "NCT06997068", "title": "Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Oral Cavity Carcinoma", "Recurrent Oral Cavity Carcinoma", "Stage IVC Lip and Oral Cavity Cancer AJCC v8", "Head and Neck Cancer", "Hypopharynx Cancer", "Oropharynx Cancer", "Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Metastatic Hypopharyngeal Carcinoma", "Metastatic Laryngeal Carcinoma", "Metastatic Malignant Head and Neck Neoplasm", "Metastatic Oropharyngeal Carcinoma", "Recurrent Hypopharyngeal Carcinoma", "Recurrent Laryngeal Carcinoma", "Recurrent Malignant Head and Neck Neoplasm", "Recurrent Oropharyngeal Carcinoma", "Stage IVC Hypopharyngeal Carcinoma AJCC v8", "Stage IVC Laryngeal Cancer AJCC v8", "Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8" ], "interventions": [ { "name": "Celecoxib", "type": "DRUG" }, { "name": "Erlotinib Hydrochloride", "type": "DRUG" }, { "name": "Imaging Procedure", "type": "PROCEDURE" }, { "name": "Interview", "type": "OTHER" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2025-08-07", "completion_date": "2029-08-05", "has_results": false, "last_update_posted_date": "2026-10-01", "last_synced_at": "2026-10-20T03:05:24.576Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06997068" }, { "nct_id": "NCT03033225", "title": "Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Advanced Pancreatic Carcinoma", "Locally Advanced Pancreatic Carcinoma", "Metastatic Pancreatic Carcinoma", "Pancreatic Neoplasm", "Stage II Pancreatic Cancer AJCC v8", "Stage III Pancreatic Cancer AJCC v8", "Stage IV Pancreatic Cancer AJCC v8", "Unresectable Pancreatic Carcinoma" ], "interventions": [ { "name": "Endoscopic Ultrasound", "type": "PROCEDURE" }, { "name": "Fluorescence Imaging", "type": "PROCEDURE" }, { "name": "Photodynamic Therapy", "type": "DRUG" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Verteporfin", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 13, "start_date": "2017-05-31", "completion_date": "2023-09-20", "has_results": true, "last_update_posted_date": "2025-07-30", "last_synced_at": "2026-10-20T03:05:24.576Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03033225" }, { "nct_id": "NCT03081767", "title": "Standard PET/CT vs. Digital PET/CT", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "Digital PET/CT scan", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 199, "start_date": "2017-03-29", "completion_date": "2021-04-01", "has_results": true, "last_update_posted_date": "2022-04-12", "last_synced_at": "2026-10-20T03:05:24.576Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03081767" }, { "nct_id": "NCT04090619", "title": "Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Advanced Malignant Solid Neoplasm", "Caregiver", "Metastatic Malignant Solid Neoplasm", "Recurrent Leukemia", "Recurrent Lymphoma", "Recurrent Malignant Solid Neoplasm", "Recurrent Plasma Cell Myeloma" ], "interventions": [ { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 192, "start_date": "2021-06-22", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-10-20T03:05:24.576Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04090619" }, { "nct_id": "NCT03163017", "title": "Assessment of Ability of 3D Fluorscopy in Aiding Accurate Syndesmotic Reduction Following Traumatic Ankle Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Displaced Ankle Fractures" ], "interventions": [ { "name": "2D Fluoroscopy", "type": "DEVICE" }, { "name": "3D Fluoroscopy", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 30, "start_date": "2017-03-01", "completion_date": "2018-09-11", "has_results": true, "last_update_posted_date": "2019-09-12", "last_synced_at": "2026-10-20T03:05:24.576Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03163017" }, { "nct_id": "NCT07505797", "title": "ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer", "Benign Breast Condition", "Breast Fibroadenoma", "Breast Neoplasms", "Breast Disease", "Breast Cancer Female", "Breast Pain", "Breast Cancer Invasive", "Breast Cancer Detection" ], "interventions": [ { "name": "ATUSA 3D Automated Breast Ultrasound System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "iSono Health, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "94 Years", "sex": "FEMALE", "summary": "18 Years to 94 Years · Female only" }, "enrollment_count": 800, "start_date": "2025-12-16", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-10-20T03:05:24.576Z", "location_count": 2, "location_summary": "Sacramento, California • Cypress, Texas", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "Cypress", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07505797" }, { "nct_id": "NCT00488293", "title": "Impact of Teledermatology on Health Services Outcomes in the Department of Veterans Affairs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Skin Diseases", "Telemedicine", "Quality of Life" ], "interventions": [ { "name": "Store and forward teledermatology", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "US Department of Veterans Affairs", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 392, "start_date": "2008-11", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2015-06-08", "last_synced_at": "2026-10-20T03:05:24.576Z", "location_count": 2, "location_summary": "Minneapolis, Minnesota • Columbia, Missouri", "locations": [ { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Columbia", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00488293" }, { "nct_id": "NCT01261559", "title": "Breast Displacement and CT Radiation Dose", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Computed Tomography", "Radiation Dosage" ], "interventions": [ { "name": "Chrysalis breast displacement device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "FEMALE", "summary": "18 Years to 60 Years · Female only" }, "enrollment_count": 72, "start_date": "2010-12", "completion_date": "2012-02", "has_results": true, "last_update_posted_date": "2018-07-06", "last_synced_at": "2026-10-20T03:05:24.576Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01261559" } ] }